Q&A: A new model reveals hidden disease signatures and predicts health outcomes
Article excerpt
by Mass General Brigham edited by Swati Mestri, reviewed by Andrew Zinin This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility: fact-checked peer-reviewed publication trusted source proofread Sarah Urbut, MD, Ph.D., of the Mass General Brigham Heart and Vascular Institute, is the lead author of a paper published in Nature, "A Bayesian framework for longitudinal EHR and genetic discovery." Pradeep Natarajan, MD, MMSc, also of the Heart and Vascular Institute, is one of the co-senior authors, along with collaborators at Harvard Medical School, Harvard T.H. Chan School of Public Health, the Broad Institute of MIT and Harvard, and Dana-Farber Cancer Institute. In medicine, there is a tendency to view different specialties - or even different diseases within the same specialty - separately, rather than borrowing information across a patient's entire disease history. Different aspects of a patient's care are often managed in silos, and their medical history is frequently treated as a snapshot in time rather than as a process that continuously evolves. Moreover, patients are typically treated according to their diagnostic label (for example, "coronary disease" or "diabetes") rather than the biological processes driving their condition. This is a major...
Keep reading with a free account
The rest of this article, and every signal for Mass General Brigham, is in your free account.
Extracted from this sentence
To help answer these questions, we developed an advanced generative model called ALADYNOULLI.
